Showing results (331-340 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|December 28, 2016
Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung CancerChan Shen, Kenneth L Kehl, Bo Zhao, et al.
Clinical Lung Cancer|January 14, 2017
RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 PatientsMichal Sarfaty, Assaf Moore, Victoria Neiman, et al.
Clinical Lung Cancer|January 2, 2017
Stereotactic Body Radiotherapy for Large (> 5 cm) Non-Small-Cell Lung CancerJustin Peterson, Christian Niles, Ashish Patel, et al.
Clinical Lung Cancer|March 26, 2017
Hippocampal-Sparing Whole-Brain Radiotherapy for Lung CancerRen Zhao, Wei Kong, Jun Shang, et al.
Clinical Lung Cancer|March 26, 2017
Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung CancerMasahiro Morimoto, Kyoichi Okishio, Masanori Akira, et al.
Clinical Lung Cancer|March 26, 2017
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage DiseaseMark A Socinski, Frederic J Kaye, David R Spigel, et al.
Clinical Lung Cancer|September 24, 2014
Metachronous and synchronous primary lung cancers: diagnostic aspects, surgical treatment, and prognosisAngeliki A Loukeri, Christos F Kampolis, Anna Ntokou, et al.
Clinical Lung Cancer|September 24, 2014
nab-Paclitaxel for the treatment of advanced squamous non-small-cell lung cancer: a comprehensive updateGeorge R Simon
Clinical Lung Cancer|September 27, 2014
Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancerGavitt A Woodard, Matthew A Gubens, Thierry M Jahan, et al.
Clinical Lung Cancer|September 16, 2014
Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiationJonathan M Robson, Sriram Vaidyanathan, Leanne Cheyne, et al.
Pageof 234